Skip to main content
. 2016 Sep 28;33(10):725–736. doi: 10.1007/s40266-016-0405-y

Fig. 3.

Fig. 3

Rivastigmine and NAP226-90 steady-state plasma concentrations versus baseline creatinine clearance and estimated glomerular filtration rate following patch application